- Home
- GDTC vs ACXP Comparison
GDTC vs ACXP Comparison
Compare GDTC & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDTC
- ACXP
- Stock Information
- Founded
- GDTC 2018
- ACXP 2017
- Country
- GDTC Singapore
- ACXP United States
- Employees
- GDTC N/A
- ACXP N/A
- Industry
- GDTC Biotechnology: Pharmaceutical Preparations
- ACXP Biotechnology: Pharmaceutical Preparations
- Sector
- GDTC Health Care
- ACXP Health Care
- Exchange
- GDTC Nasdaq
- ACXP Nasdaq
- Market Cap
- GDTC 33.4M
- ACXP 31.4M
- IPO Year
- GDTC 2023
- ACXP 2021
- Fundamental
- Price
- GDTC $2.38
- ACXP $0.88
- Analyst Decision
- GDTC Buy
- ACXP Strong Buy
- Analyst Count
- GDTC 1
- ACXP 1
- Target Price
- GDTC $5.00
- ACXP $12.00
- AVG Volume (30 Days)
- GDTC 597.0K
- ACXP 455.1K
- Earning Date
- GDTC 01-01-0001
- ACXP 03-14-2025
- Dividend Yield
- GDTC N/A
- ACXP N/A
- EPS Growth
- GDTC N/A
- ACXP N/A
- EPS
- GDTC N/A
- ACXP N/A
- Revenue
- GDTC $330,254.00
- ACXP N/A
- Revenue This Year
- GDTC $14.71
- ACXP N/A
- Revenue Next Year
- GDTC N/A
- ACXP N/A
- P/E Ratio
- GDTC N/A
- ACXP N/A
- Revenue Growth
- GDTC N/A
- ACXP N/A
- 52 Week Low
- GDTC $1.20
- ACXP $0.68
- 52 Week High
- GDTC $4.30
- ACXP $4.15
- Technical
- Relative Strength Index (RSI)
- GDTC 44.91
- ACXP 49.25
- Support Level
- GDTC $2.12
- ACXP $0.68
- Resistance Level
- GDTC $2.64
- ACXP $1.25
- Average True Range (ATR)
- GDTC 0.48
- ACXP 0.10
- MACD
- GDTC -0.10
- ACXP 0.02
- Stochastic Oscillator
- GDTC 13.47
- ACXP 35.61
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.